BioLife Solutions BLFS Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's available-for-sale debt securities - unrealized loss position (<12 months).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's available-for-sale debt securities - unrealized loss position (<12 months)?
- BioLife Solutions (BLFS) reported available-for-sale debt securities - unrealized loss position (<12 months) of $57.93M in Q1 2026.
- How has BioLife Solutions's available-for-sale debt securities - unrealized loss position (<12 months) changed year-over-year?
- BioLife Solutions's available-for-sale debt securities - unrealized loss position (<12 months) increased by 479.6% year-over-year, from $10M to $57.93M.